0

Nanoxel

Nanoxel
Nanoxel
Product Description
COMPOSITION:
Paclitaxel Nanoparticle Injection (NANOXEL) comprises of essentially two vials, namely:
1. One vial of Paclitaxel Solution for Nanoparticle
Each ml contains:
Paclitaxel IP………………20 mg
Dehydrated  IP……...q.s.
2. One vial of Concentrate of Excipients for NANOXEL
Each ml contains:
Polymer PNP……………… 10 mg
Other Excipients…………….q.s.
Water for Injection IP……….q.s.

INDICATIONS :
 
NANOXEL is indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy.
NANOXEL is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.
NANOXEL is indicated as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary. As firstline therapy, NANOXEL is indicated in combination with cisplatin.
NANOXEL, in combination with cisplatin, is indicated for the first-line treatment of non-small cell lung cancer in patients who are not candidates for potentially curative surgery and/or radiation therapy.
NANOXEL is indicated for the second-line treatment of AIDS-related Kaposi's sarcoma.
   
PRESENTATION :
 
NANOXEL is available as a combination pack containing one vial of “Paclitaxel Solution for Nanoparticle” and one vial of
“Concentrate of excipients for NANOXEL”.
Paclitaxel Solution for Nanoparticle is available in vials of 1.5 ml (30 mg), 5 ml (100 mg) & 15 ml (300 mg).
“Concentrate of excipients for NANOXEL” is also available in vials of 1.5 ml, 5 ml and 15 ml.
Contact Us

5, SUNDERVAN SOCIETY, NEAR NAVGUJARAT COLLEGE, ASHRAM ROAD, USMANPURA, Ahmedabad, Gujarat, 380014, India
Phone :+918037745088